WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002026812) A NOVEL PEPTIDE---HUMAN DNA CGG REPEATED ASSOCIATIVE PROTEIN 16.17 AND THE POLYNUCLEOTIDE CODING THIS NOVEL PEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/026812    International Application No.:    PCT/CN2001/000910
Publication Date: 04.04.2002 International Filing Date: 04.06.2001
IPC:
A61K 38/00 (2006.01), A61K 48/00 (2006.01), C07K 14/47 (2006.01)
Applicants: SHANGHAI BIOWINDOW GENE DEVELOPMENT INC. [CN/CN]; 3rd Building 12th Floor 1111 Zhongshan Bei Er Road Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI HUA DONG PATENT AGENCY; 319 Yue Yang Road Shanghai 200031 (CN)
Priority Data:
00 1 16383.3 07.06.2000 CN
Title (EN) A NOVEL PEPTIDE---HUMAN DNA CGG REPEATED ASSOCIATIVE PROTEIN 16.17 AND THE POLYNUCLEOTIDE CODING THIS NOVEL PEPTIDE
(FR) NOUVEAU POLYPEPTIDE, PROTEINE DE TYPE HUMAIN 16.17 DE LIAISON A LA REPETITION ADN CGG, ET POLYNUCLEOTIDE CODANT CE POLYPEPTIDE
Abstract: front page image
(EN)The invention disclosed a novel peptide--- Human DNA CGG Repeated associative protein 16.17, polynucleotide coding this peptide and the method producing this peptide by DNA recombination techniques. This invention also disclosed the therapeutical methods with this peptide for several diseases, such as embryo heteroplasia, tumors and illness of protein decompensation, et al. This invention also disclosed an antagonist against this peptide and its therapeutical effect. The invention also disclosed the use of this polynucleotide coding the novel human DNA CGG Repeated associative protein 16.17.
(FR)L'invention concerne un nouveau polypeptide, une protéine de type humain 16.17 de liaison à la répétition ADN CGG, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de malformations lors du développement de l'embryon, de tumeurs et de maladies liées aux troubles du métabolisme protéique. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant la protéine de type humain 16.17 de liaison à la répétition ADN CGG.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)